Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer

NCT00017394 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: vinorelbine tartrate
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)